Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Stem Cells. 2012 Apr;30(4):591–598. doi: 10.1002/stem.1061

Figure 3.

Figure 3

LRCCs exhibit greater tumor-initiating capacity than non-LRCC. (A): Tumors generated by only 10 LRCC (green arrow). Transponders used in the blinding procedure (white arrow). A tumor is demonstrated on the right. (B, C): Two cell lines were used: PLC/PRF/5 (hepatocellular carcinoma) and fresh colorectal cancer (CSCL-04-Ke). In a blinded experiment, 14/20 versus 2/20 of the animals grew tumors from only 10 cells (p = .0005, Fisher's exact). Abbreviation: LRCC, label-retaining cancer cell.